HACKENSACK, N.J., Nov. 7 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. announced today that its CFO, Barbara Duncan, will present at the CIBC World Markets 16th Annual Healthcare Conference on Tuesday, November 8, 2005. Her presentation, scheduled to begin at 2:00 p.m. ET, will be webcast live from The Waldorf-Astoria Hotel in New York City. Ms. Duncan will provide an overview of the company’s corporate strategy and ongoing development programs.
The webcast of the presentation may be accessed through the following link: http://conferences.cibcwm.com/health05/ When prompted, please use the webcast source code: november. Presentations will be archived and available on the investor relations section of DOV’s website: http://www.dovpharm.com after the conference for 90 days.
About DOV
DOV is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system and other disorders, including cardiovascular, that involve alterations in neuronal processing. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, pain and depression. Our partner Neurocrine has filed two NDA’s for the use of DOV’s compound indiplon for the treatment of insomnia.
DOV Pharmaceutical, Inc.
CONTACT: Alan Beckhard, Manager, Investor Relations and CorporateCommunications of DOV Pharmaceutical, Inc., +1-201-968-0980
Web site: http://www.dovpharm.com/
